Mar
26
2020

COVID-19 Vaccine Study COV001

By OVG

What is the purpose of this trial?

The purpose of this study is to test a new vaccine against COVID-19 in healthy volunteers.

A new virus causing respiratory disease emerged in Wuhan, China in December 2019 and has since rapidly spread to many other countries around the world, despite unprecedented containment efforts. The virus is part of the Coronavirus family which may cause respiratory infections ranging from the common cold to more severe diseases. This recently discovered coronavirus causes coronavirus disease COVID-19.

Apr
25
2019

Understanding RSV: Severe disease and the long term consequences

By OVG

Understanding RSV: Severe disease and the long term consequences

Oxford Vaccine Group are inviting volunteers to take part in a study to help us learn more about the virus that most commonly causes coughs, colds and chest infections in young children, and sometimes causes children to be so unwell they have to be admitted to hospital.

Some facts about RSV disease (respiratory syncytial virus):

Mar
12
2018

Be on the TEAM: Teenagers against Meningitis

By OVG

The Oxford Vaccine Group are inviting students in school year 12 to take part in a research project to understand whether immunising teenagers with vaccines against ‘Meningitis B’ could protect them and the rest of the community against these potentially deadly bacteria. This is a national study involving 24 000 year 12 students across the United Kingdom.  Teenagers at participating schools are being asked to take part by local research teams involved.

Aug
30
2017

Burden of RSV Disease

By OVG

Some facts about RSV disease (respiratory syncytial virus):

RSV is a virus;

  • it causes coughs, colds and chest infections
  • is responsible for around 1 in 6 hospital admissions for infants  in the UK
  • The second largest worldwide cause of deaths in children between one month and 1 year of age, most are in Asia and Africa

What do we want to do?

We would like to identify 2000 babies from birth and follow them up to see if any become unwell with RSV disease

Aug
31
2016

Ebola Vaccine Registry Study

By OVG

THIS STUDY IS NOW IN FOLLOW UP

What is the purpose of this study?

Eligible participants for this study have previously received an experimental Ebola vaccine- Ad26.ZEBOV and MVA-BN-Filo. The purpose of this study is to collect long-term safety data from these participants who received two experimental vaccines to prevent Ebola virus disease. This may contribute to the future development of an Ebola vaccine.

Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, University of Oxford, OX3 7LE.

This unit receives National Institute for Health Research CTU Support Funding. This funding has been awarded to support the unit in developing and supporting NIHR trials.